International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 112

Research Paper | Pharmaceutical Science | Volume 7 Issue 1, January 2018 | Pages: 1611 - 1622 | Ukraine


Substantiation of Rational Choice of Statin Therapy in Ukraine

Oksana Tryhubchak

Abstract: This study was conducted using marketing, pharmacoeconomical research of statins in Ukraine. It was found that the largest number of people taking statins use atorvastatin (51 %), simvastatin (31 %), rosuvastatin (16 %), lovastatin (2 %). costs minimization, cost-effectiveness and cost-utility analysis it was chose the least costly statins in Ukraine. We found differences in seven Issues of State Formulary of Drugs in Ukraine for the statin groups. The well-founded pharmacoeconomic benefits of rosuvastatin 10 mg included reducing the risk of morbidity and mortality, for atorvasatin 10 mg the reducing of low-density lipoprotein

Keywords: statin, rational choice, market analysis, pharmacoeconomics, pharmacoepidemiology

How to Cite?: Oksana Tryhubchak, "Substantiation of Rational Choice of Statin Therapy in Ukraine", Volume 7 Issue 1, January 2018, International Journal of Science and Research (IJSR), Pages: 1611-1622, https://www.ijsr.net/getabstract.php?paperid=ART20179723, DOI: https://dx.doi.org/10.21275/ART20179723

Download Citation: APA | MLA | BibTeX | EndNote | RefMan

Share This Research

Help this article reach readers, researchers and professionals.

Share activity is measured for research-engagement analytics. Only verified, unique public shares can support award tie-breaking.

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.

Download Article PDF


Rate This Article!

Top

Confirm Your Share

Enter your details so IJSR can confirm this sharing activity.

Your details are used to validate this share and protect the award process from duplicate or false activity.